2021 Speakers

 

Dr Brian Abel, Senior Director of Program Development, Aegis Life, Inc.

Dr Brian Abel | Senior Director of Program Development | Aegis Life, Inc. » speaking at Antiviral Congress 2021

Dr Nicholas Abuid, Field Application Scientist, ACROBiosystems Inc.

Dr Nicholas Abuid | Field Application Scientist | ACROBiosystems Inc. » speaking at Antiviral Congress 2021

David Anderson, Chief Scientific Officer, VBI Vaccines

David Anderson | Chief Scientific Officer | VBI Vaccines » speaking at Antiviral Congress 2021

Dr James Appleman, SVP R&D and CSO, Primmune Therapeutics, Inc.

Dr James Appleman | SVP R&D and CSO | Primmune Therapeutics, Inc. » speaking at Antiviral Congress 2021

Kimberly Armstrong, Chief of the Therapeutics Branch in the Influenza and Emerging Infectious Diseases Division, BARDA

Kimberly Armstrong | Chief of the Therapeutics Branch in the Influenza and Emerging Infectious Diseases Division | BARDA » speaking at Antiviral Congress 2021

Kabeer Aziz, Co-Founder & Principal, Adjuvant Capital

Kabeer Aziz | Co-Founder & Principal | Adjuvant Capital » speaking at Antiviral Congress 2021

Dr Andrew Badley, Chair, Mayo Clinic COVID-19 Research Taskforce, Mayo Clinic

Dr Andrew Badley | Chair, Mayo Clinic COVID-19 Research Taskforce | Mayo Clinic » speaking at Antiviral Congress 2021

Dr Jared Baeten, Vice President, HIV Clinical Development, Gilead Sciences

Dr Jared Baeten | Vice President, HIV Clinical Development | Gilead Sciences » speaking at Antiviral Congress 2021

Carlos Bais, Senior Director, Oncology Biomarker Development, Genenetch Inc

Carlos Bais | Senior Director, Oncology Biomarker Development | Genenetch Inc » speaking at Antiviral Congress 2021

Dr Jessica Baker Flechtner, Chief Scientific Officer, Genocea Biosciences

Dr Jessica Baker Flechtner | Chief Scientific Officer | Genocea Biosciences » speaking at Antiviral Congress 2021

Lance Baldo, Chief Medical Officer, Adaptive Biotechnologies

Lance Baldo | Chief Medical Officer | Adaptive Biotechnologies » speaking at Antiviral Congress 2021

Dr Carl Barrett, Vice President Of Translational Sciences, AstraZeneca

Dr Carl Barrett | Vice President Of Translational Sciences | AstraZeneca » speaking at Antiviral Congress 2021

Tommy Begres, Sr. Director, Medical Affairs, Emergent BioSolutions

Tommy Begres | Sr. Director, Medical Affairs | Emergent BioSolutions » speaking at Antiviral Congress 2021

Dr John Beigel, Associate Director, Clinical Research, National Institute of Health - NIAID

Dr John Beigel | Associate Director, Clinical Research | National Institute of Health - NIAID » speaking at Antiviral Congress 2021

Sharon Benzeno, Chief Business Development Officer, Adaptive Biotechnologies

Sharon Benzeno | Chief Business Development Officer | Adaptive Biotechnologies » speaking at Antiviral Congress 2021

Dr. David Berd, Chief Medical Officer, BioVaxys Technology Corp.

Dr. David Berd | Chief Medical Officer | BioVaxys Technology Corp. » speaking at Antiviral Congress 2021

Prof. Pamela Bjorkman, David Baltimore Professor of Biology and Biological Engineering, California Institute of Technology

Prof. Pamela Bjorkman | David Baltimore Professor of Biology and Biological Engineering | California Institute of Technology » speaking at Antiviral Congress 2021

Mohan Bolisetty, Associate Director, Bristol-Myers Squibb

Mohan Bolisetty | Associate Director | Bristol-Myers Squibb » speaking at Antiviral Congress 2021

Jeffrey Borgia, Assoc. Professor, Department of Pathology, Department of Cell & Molecular Medicine, Rush University Medical Center

Jeffrey Borgia | Assoc. Professor, Department of Pathology, Department of Cell & Molecular Medicine | Rush University Medical Center » speaking at Antiviral Congress 2021

Dr David Boulware, Professor Of Medicine, University of Minnesota

Dr David Boulware | Professor Of Medicine | University of Minnesota » speaking at Antiviral Congress 2021

Abby Bownas, Principal, AVAC

Abby Bownas | Principal | AVAC » speaking at Antiviral Congress 2021

Dr Sarah Browne, Senior Director, Clinical Development, Altimmune

Dr Sarah Browne | Senior Director, Clinical Development | Altimmune » speaking at Antiviral Congress 2021

Rob Burgess, Chief Business Officer, Sino Biological Inc

Rob Burgess | Chief Business Officer | Sino Biological Inc » speaking at Antiviral Congress 2021

Dr Dennis Burton, Chair, Department of Immunology and Microbiology, The Scripps Research Institute

Dr Dennis Burton | Chair, Department of Immunology and Microbiology | The Scripps Research Institute » speaking at Antiviral Congress 2021

David Canton, Senior Director, R&D And Clinical Science, OncoSec Medical

David Canton | Senior Director, R&D And Clinical Science | OncoSec Medical » speaking at Antiviral Congress 2021

Sumit Chanda, Professor, Department of Immunology and Microbiology, The Scripps Research Institute

Sumit Chanda | Professor, Department of Immunology and Microbiology | The Scripps Research Institute » speaking at Antiviral Congress 2021

Dr Tomas Cihlar, Vice President, Virology, Gilead Sciences, Inc.

Dr Tomas Cihlar | Vice President, Virology | Gilead Sciences, Inc. » speaking at Antiviral Congress 2021

Dr Ezra Cohen, Associate Director Of Moores Cancer Center, U.C. San Diego Moores Cancer Center

Dr Ezra Cohen | Associate Director Of Moores Cancer Center | U.C. San Diego Moores Cancer Center » speaking at Antiviral Congress 2021

Keegan Cooke, Principal Scientist, Amgen

Keegan Cooke | Principal Scientist | Amgen » speaking at Antiviral Congress 2021

James Crowe, Director, Vanderbilt Vaccine Center

James Crowe | Director | Vanderbilt Vaccine Center » speaking at Antiviral Congress 2021

Dr James Crowe, Director, Vanderbilt Vaccine Center

Dr James Crowe | Director | Vanderbilt Vaccine Center » speaking at Antiviral Congress 2021

Dr Diane Da Silva, Associate Director, Translational Medicine, Parker Institute for Cancer Immunotherapy

Dr Diane Da Silva | Associate Director, Translational Medicine | Parker Institute for Cancer Immunotherapy » speaking at Antiviral Congress 2021

Dr Rea Dabelic, Market Development Manager, 10x Genomics

Dr Rea Dabelic | Market Development Manager | 10x Genomics » speaking at Antiviral Congress 2021

Heather Darby, Scientific and Applications Marketing Manager, LTG, Luminex Corporation

Heather Darby | Scientific and Applications Marketing Manager, LTG | Luminex Corporation » speaking at Antiviral Congress 2021

Dr Mindy Davis, Program Officer - Antiviral Discovery, NIH

Dr Mindy Davis | Program Officer - Antiviral Discovery | NIH » speaking at Antiviral Congress 2021

Dr Steven Deeks, Professor of Medicine, University of California San Francisco

Dr Steven Deeks | Professor of Medicine | University of California San Francisco » speaking at Antiviral Congress 2021

Manisha Diaz, Associate Director, Research and Development, Eurofins Viracor Biopharma

Manisha Diaz | Associate Director, Research and Development | Eurofins Viracor Biopharma » speaking at Antiviral Congress 2021

David Dominguez, Research Associate, Takeda

David Dominguez | Research Associate | Takeda » speaking at Antiviral Congress 2021

Amber Donahue, Director, Translational Medicine, Instil Bio

Amber Donahue | Director, Translational Medicine | Instil Bio » speaking at Antiviral Congress 2021

Dr Nathan Duval, Scientist, NTx

Dr Nathan Duval | Scientist | NTx » speaking at Antiviral Congress 2021

David Ede, Technology Consultant - Viral Based Therapeutics, Sartorius Stedim Biotech

David Ede | Technology Consultant - Viral Based Therapeutics | Sartorius Stedim Biotech » speaking at Antiviral Congress 2021

Peter Ehrenkranz, Deputy Director, HIV Testing and Treatment, Bill & Melinda Gates Foundation

Peter Ehrenkranz | Deputy Director, HIV Testing and Treatment | Bill & Melinda Gates Foundation » speaking at Antiviral Congress 2021

Vanessa Elharrar, Vice President, Vaccines Business Strategy Lead, ppd

Vanessa Elharrar | Vice President, Vaccines Business Strategy Lead | ppd » speaking at Antiviral Congress 2021

Dr Tom Evans, Chief Scientific Officer, Vaccitech

Dr Tom Evans | Chief Scientific Officer | Vaccitech » speaking at Antiviral Congress 2021

Kimberly Finn, VP, Global Patient Centric Service and PM, Marken

Kimberly Finn | VP, Global Patient Centric Service and PM | Marken » speaking at Antiviral Congress 2021

Denise Foster, COVID-19 Vaccine Clinical Director, Chief Nursing Officer, Medical Care Services, County of San Diego Health and Human Services

Denise Foster | COVID-19 Vaccine Clinical Director, Chief Nursing Officer, Medical Care Services | County of San Diego Health and Human Services » speaking at Antiviral Congress 2021

Dr Felix Frueh, CSO and Co-Founder, Selva Therapeutics, Inc.

Dr Felix Frueh | CSO and Co-Founder | Selva Therapeutics, Inc. » speaking at Antiviral Congress 2021

Scott Fu, Sales Specialist, InDevR

Scott Fu | Sales Specialist | InDevR » speaking at Antiviral Congress 2021

Dr Hanspeter Gerber, CSO, 3T Biosciences

Dr Hanspeter Gerber | CSO | 3T Biosciences » speaking at Antiviral Congress 2021

Brad Gessner, Vice President, Global Medical Lead For Pneumococcal Vaccines, Pfizer

Brad Gessner | Vice President, Global Medical Lead For Pneumococcal Vaccines | Pfizer » speaking at Antiviral Congress 2021

Dr Robert Gish, Managing Director, Hepatitis B. Foundation

Dr Robert Gish | Managing Director | Hepatitis B. Foundation » speaking at Antiviral Congress 2021

Dr Jeffrey Glenn, Professor of Medicine and of Microbiology & Immunology, Stanford University

Dr Jeffrey Glenn | Professor of Medicine and of Microbiology & Immunology | Stanford University » speaking at Antiviral Congress 2021

Dr Anna-Dorothea Gorki, CSO, G.ST Antivirals

Dr Anna-Dorothea Gorki | CSO | G.ST Antivirals » speaking at Antiviral Congress 2021

Anna-Dorothea Gorki, CSO, G.ST Antivirals

Anna-Dorothea Gorki | CSO | G.ST Antivirals » speaking at Antiviral Congress 2021

John Gregg, CEO, Balinbac Therapeutics, Inc.

John Gregg | CEO | Balinbac Therapeutics, Inc. » speaking at Antiviral Congress 2021

Dr Farshad Guirakhoo, Chief Scientific Officer, vaxxinity

Dr Farshad Guirakhoo | Chief Scientific Officer | vaxxinity » speaking at Antiviral Congress 2021

Serhat Gumrukcu, Inventor and Co-founder, Enochian BioSciences

Serhat Gumrukcu | Inventor and Co-founder | Enochian BioSciences » speaking at Antiviral Congress 2021

Kathryn Hashey, US Vaccine Policy Lead, GSK

Kathryn Hashey | US Vaccine Policy Lead | GSK » speaking at Antiviral Congress 2021

Mary Hauser, Senior Scientist, GeoVax, Inc.

Mary Hauser | Senior Scientist | GeoVax, Inc. » speaking at Antiviral Congress 2021

Daniel Henderson, CEO, CSO, Verndari

Daniel Henderson | CEO, CSO | Verndari » speaking at Antiviral Congress 2021

Ted Hibben, CBO, Vaxess

Ted Hibben | CBO | Vaxess » speaking at Antiviral Congress 2021

Daniel Hollern, Assistant Professor, Assistant Professor, NOMIS Center for Immunobiology and Microbial Pathogenesis, The Salk Institute

Daniel Hollern | Assistant Professor, Assistant Professor, NOMIS Center for Immunobiology and Microbial Pathogenesis | The Salk Institute » speaking at Antiviral Congress 2021

Dr Karl Hostetler, Professor of Medicine, University of California San Diego

Dr Karl Hostetler | Professor of Medicine | University of California San Diego » speaking at Antiviral Congress 2021

Eric Ibsen, CEO, Studylog

Eric Ibsen | CEO | Studylog » speaking at Antiviral Congress 2021

Dr Michael Ison, Professor Of Medicine, Northwestern University

Dr Michael Ison | Professor Of Medicine | Northwestern University » speaking at Antiviral Congress 2021

Dr Amy Jenkins, Program Manager, D.A.R.P.A.

Dr Amy Jenkins | Program Manager | D.A.R.P.A. » speaking at Antiviral Congress 2021

Karin Jooss, CSO, Gritstone Oncology

Karin Jooss | CSO | Gritstone Oncology » speaking at Antiviral Congress 2021

Dr Robert Jordan, Senior Program Officer, Bill & Melinda Gates Foundation

Dr Robert Jordan | Senior Program Officer | Bill & Melinda Gates Foundation » speaking at Antiviral Congress 2021

Maria Karasarides, Vice-President, Head Early Assets & Biomarkers, Bristol-Myers Squibb

Maria Karasarides | Vice-President, Head Early Assets & Biomarkers | Bristol-Myers Squibb » speaking at Antiviral Congress 2021

Dr Scott Kelly, CMO, CytoDyn, Inc.

Dr Scott Kelly | CMO | CytoDyn, Inc. » speaking at Antiviral Congress 2021

Kevin Killeen, Chief Scientific Officer, Matrivax R & D Corp

Kevin Killeen | Chief Scientific Officer | Matrivax R & D Corp » speaking at Antiviral Congress 2021

Alexander Kort, SVP Corporate Development, Themis Bioscience

Alexander Kort | SVP Corporate Development | Themis Bioscience » speaking at Antiviral Congress 2021

Tom Lake, SVP, Strategic Alliances & Commercialization, Vaxxas

Tom Lake | SVP, Strategic Alliances & Commercialization | Vaxxas » speaking at Antiviral Congress 2021

Rekha Lakshmanan, Contributing Expert, Rice University’s Baker Institute for Public Policy; Director, Advocacy And Policy, The Immunization Partnership

Rekha Lakshmanan | Contributing Expert, Rice University’s Baker Institute for Public Policy; Director, Advocacy And Policy | The Immunization Partnership » speaking at Antiviral Congress 2021

Brandon Lamarche, Principal Scientist, Head of xCELLigence Application Development, Agilent

Brandon Lamarche | Principal Scientist, Head of xCELLigence Application Development | Agilent » speaking at Antiviral Congress 2021

Christopher Larson, Vice President of Viral Therapy, EpicentRx

Christopher Larson | Vice President of Viral Therapy | EpicentRx » speaking at Antiviral Congress 2021

David F. Lasseter, Former Deputy Assistant Secretary of Defense for Countering Weapons of Mass Destruction at DoD; Consultant,, Horizons Global Solutions

David F. Lasseter | Former Deputy Assistant Secretary of Defense for Countering Weapons of Mass Destruction at DoD; Consultant, | Horizons Global Solutions » speaking at Antiviral Congress 2021

Dr Sam Lee, President, Cocrystal Pharma, Inc.

Dr Sam Lee | President | Cocrystal Pharma, Inc. » speaking at Antiviral Congress 2021

Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital Harvard Medical School

Ofer Levy | Director, Precision Vaccines Program | Boston Children's Hospital Harvard Medical School » speaking at Antiviral Congress 2021

Dr Rachel Liberatore, Director of Research & Development, Renbio

Dr Rachel Liberatore | Director of Research & Development | Renbio » speaking at Antiviral Congress 2021

Dr Elke Lipka, Ph.D, MBA, CEO, TSRL, Inc

Dr Elke Lipka, Ph.D, MBA | CEO | TSRL, Inc » speaking at Antiviral Congress 2021

Bruce Lyday, Chief Technology Officer, Primevax Immuno-Oncology, Inc.

Bruce Lyday | Chief Technology Officer | Primevax Immuno-Oncology, Inc. » speaking at Antiviral Congress 2021

Shelly Malhotra, Senior Director, Global Access, IAVI

Shelly Malhotra | Senior Director, Global Access | IAVI » speaking at Antiviral Congress 2021

Alex Mann, Senior Director, Clinical Sciences, hVIVO

Alex Mann | Senior Director, Clinical Sciences | hVIVO » speaking at Antiviral Congress 2021

Dr Tyler Martin, Chairman, President & CEO, Adjuvance Technologies

Dr Tyler Martin | Chairman, President & CEO | Adjuvance Technologies » speaking at Antiviral Congress 2021

Kevin McCowen, Southwest Regional Manager, Wyatt Technology Corporation

Kevin McCowen | Southwest Regional Manager | Wyatt Technology Corporation » speaking at Antiviral Congress 2021

Mark McDade, Managing Partner, Qiming Venture Partners

Mark McDade | Managing Partner | Qiming Venture Partners » speaking at Antiviral Congress 2021

Dr Jonathan Mercado, Biotech Consultant, IsoPlexis

Dr Jonathan Mercado | Biotech Consultant | IsoPlexis » speaking at Antiviral Congress 2021

Dr James Merson, Global Therapeutic Area Head, Infectious Diseases, Janssen

Dr James Merson | Global Therapeutic Area Head, Infectious Diseases | Janssen » speaking at Antiviral Congress 2021

Jacqueline Miller, Senior Vice President, Therapeutic Area Head, Infectious Disease, Moderna Therapeutics

Jacqueline Miller | Senior Vice President, Therapeutic Area Head, Infectious Disease | Moderna Therapeutics » speaking at Antiviral Congress 2021

Lenny Moise, Director of Vaccine Research, EpiVax Inc

Lenny Moise | Director of Vaccine Research | EpiVax Inc » speaking at Antiviral Congress 2021

Sandrine Miller Montgomery, President & CEO, Micronoma

Sandrine Miller Montgomery | President & CEO | Micronoma » speaking at Antiviral Congress 2021

Vincent Munster, Chief of Virus Ecology Unit, NIAID, NIH

Vincent Munster | Chief of Virus Ecology Unit | NIAID, NIH » speaking at Antiviral Congress 2021

Mark Newman, CSO, GeoVax, Inc.

Mark Newman | CSO | GeoVax, Inc. » speaking at Antiviral Congress 2021

Toyin Nwafor, Regional Medical Director, ViiV healthcare

Toyin Nwafor | Regional Medical Director | ViiV healthcare » speaking at Antiviral Congress 2021

Dr Neal Padte, Chief Operating Officer & Chief Development Officer, Renbio

Dr Neal Padte | Chief Operating Officer & Chief Development Officer | Renbio » speaking at Antiviral Congress 2021

Dr Wendy Painter, Chief Medical Officer, Ridgeback Biotherapeutics

Dr Wendy Painter | Chief Medical Officer | Ridgeback Biotherapeutics » speaking at Antiviral Congress 2021

Dr George Painter, Professor of Pharmacology and Chemical Biology, Emory University

Dr George Painter | Professor of Pharmacology and Chemical Biology | Emory University » speaking at Antiviral Congress 2021

Jason Paragas, President, SaponiQx

Jason Paragas | President | SaponiQx » speaking at Antiviral Congress 2021

Dr Gaston Picchio, Chief Development Officer, Arbutus Biopharma Corporation

Dr Gaston Picchio | Chief Development Officer | Arbutus Biopharma Corporation » speaking at Antiviral Congress 2021

Robert Popovian, Senior Health Policy Fellow, Progressive Policy Institute

Robert Popovian | Senior Health Policy Fellow | Progressive Policy Institute » speaking at Antiviral Congress 2021

Krishna Prasad, Founder, Citranvi Biosciences LLC

Krishna Prasad | Founder | Citranvi Biosciences LLC » speaking at Antiviral Congress 2021

kamal puri, CSO, OncoResponse

kamal puri | CSO | OncoResponse » speaking at Antiviral Congress 2021

Dr Barbara Rath, Chair of the ISIRV Epidemiology Group and Board Member with ISIRV and ESGREV and Co-founder & Chair, Vienna Vaccine Safety Initiative

Dr Barbara Rath | Chair of the ISIRV Epidemiology Group and Board Member with ISIRV and ESGREV and Co-founder & Chair | Vienna Vaccine Safety Initiative » speaking at Antiviral Congress 2021

Dr Douglas Richman, Director, Center for Aids Research, University of California San Diego

Dr Douglas Richman | Director, Center for Aids Research | University of California San Diego » speaking at Antiviral Congress 2021

Paul Robbins, Vice President, Translational Oncology, Instil Bio

Paul Robbins | Vice President, Translational  Oncology | Instil Bio » speaking at Antiviral Congress 2021

Kari Roberts, Business Development Manager, Microbiologics Inc

Kari Roberts | Business Development Manager | Microbiologics Inc » speaking at Antiviral Congress 2021

Paul Schaper, Executive Director of Global Pharmaceutical Public Policy, Merck

Paul Schaper | Executive Director of Global Pharmaceutical Public Policy | Merck » speaking at Antiviral Congress 2021

Richard Scheuermann, Director, J. Craig Venter Institute

Richard Scheuermann | Director | J. Craig Venter Institute » speaking at Antiviral Congress 2021

Stephen Schoenberger, Professor, La Jolla Institute for Allergy and Immunology

Stephen Schoenberger | Professor | La Jolla Institute for Allergy and Immunology » speaking at Antiviral Congress 2021

Dr Kathie Seley-Radtke, Professor Chemistry & Biochemistry, University of Maryland Baltimore County

Dr Kathie Seley-Radtke | Professor Chemistry & Biochemistry | University of Maryland Baltimore County » speaking at Antiviral Congress 2021

Barbara Sennino, Senior Director, Tumor Immunology, PACT Pharma, Inc

Barbara Sennino | Senior Director, Tumor Immunology | PACT Pharma, Inc » speaking at Antiviral Congress 2021

Alessandro Sette, Center Head, Division Head, And Professor,, La Jolla Institute for Allergy and Immunology

Alessandro Sette | Center Head, Division Head, And Professor, | La Jolla Institute for Allergy and Immunology » speaking at Antiviral Congress 2021

Dr Robert Shafer, Professor of Medicine-Infectious Diseases, Stanford University School of Medicine (USA)

Dr Robert Shafer | Professor of Medicine-Infectious Diseases | Stanford University School of Medicine (USA) » speaking at Antiviral Congress 2021

Sonia Sharma, Assistant Professor and Director of the Division of Cell Biology, La Jolla Institute

Sonia Sharma | Assistant Professor and Director of the Division of Cell Biology | La Jolla Institute » speaking at Antiviral Congress 2021

Dr Leah Sibener, Co-Founder, Head of Therapeutic Discovery, 3T Biosciences

Dr Leah Sibener | Co-Founder, Head of Therapeutic Discovery | 3T Biosciences » speaking at Antiviral Congress 2021

Adam Simpson, Co-Founder And Chief Executive Officer, Icosavax, Inc.

Adam Simpson | Co-Founder And Chief Executive Officer | Icosavax, Inc. » speaking at Antiviral Congress 2021

William Smith, PI/CEO, Alliance for Multispecialty Research LLC

William Smith | PI/CEO | Alliance for Multispecialty Research LLC » speaking at Antiviral Congress 2021

Trevor Smith, VP of Preclinical Developments, Inovio Pharmaceuticals

Trevor Smith | VP of Preclinical Developments | Inovio Pharmaceuticals » speaking at Antiviral Congress 2021

Tim Soos, Director Immunology, Codiak Biosciences

Tim Soos | Director Immunology | Codiak Biosciences » speaking at Antiviral Congress 2021

Dr Erin Spiegel, VP Clinical & Regulatory Affairs, PharmaJet

Dr Erin Spiegel | VP Clinical & Regulatory Affairs | PharmaJet » speaking at Antiviral Congress 2021

Mike Stebbins, Executive Director, Medical CBRN Defense Consortium

Mike Stebbins | Executive Director | Medical CBRN Defense Consortium » speaking at Antiviral Congress 2021

Dr Eddie Sullivan, President, Chief Executive Officer And Co-Founder, Sab Biotherapeutics Inc

Dr Eddie Sullivan | President, Chief Executive Officer And Co-Founder | Sab Biotherapeutics Inc » speaking at Antiviral Congress 2021

Dr Todd Suscovich, Chief Technology Officer, Seromyx

Dr Todd Suscovich | Chief Technology Officer | Seromyx » speaking at Antiviral Congress 2021

Dr Pablo Tamayo, Co-Director, Cancer Center Genomics And Computational Biology Shared Resource, Professor, Division O, University of California, San Diego (UCSD)

Dr Pablo Tamayo | Co-Director, Cancer Center Genomics And Computational Biology Shared Resource, Professor, Division O | University of California, San Diego (UCSD) » speaking at Antiviral Congress 2021

Dr Vu Truong, Chief Executive Officer And Chief Scientific Officer, Aridis Pharmaceuticals

Dr Vu Truong | Chief Executive Officer And Chief Scientific Officer | Aridis Pharmaceuticals » speaking at Antiviral Congress 2021

Dr Heidi Trusheim, Head of Process Development, IDT Biologika

Dr Heidi Trusheim | Head of Process Development | IDT Biologika » speaking at Antiviral Congress 2021

Dr Sean Tucker, Chief Scientific Officer And Vice President Research, Vaxart

Dr Sean Tucker | Chief Scientific Officer And Vice President Research | Vaxart » speaking at Antiviral Congress 2021

Dr Andrew Vaillant, Chief Scientific Officer, Replicor Inc.

Dr Andrew Vaillant | Chief Scientific Officer | Replicor Inc. » speaking at Antiviral Congress 2021

Prof. Wim Van Criekinge, Professor, myNEO NV

Prof. Wim Van Criekinge | Professor | myNEO NV » speaking at Antiviral Congress 2021

Robert Walker, Chief Medical Officer, Meissa Vaccines, Inc

Robert Walker | Chief Medical Officer | Meissa Vaccines, Inc » speaking at Antiviral Congress 2021

Dr Laura Walker, Chief Scientific Officer, Adagio Therapeutics

Dr Laura Walker | Chief Scientific Officer | Adagio Therapeutics » speaking at Antiviral Congress 2021

James Wassil, COO, Vaxcyte

James Wassil | COO | Vaxcyte » speaking at Antiviral Congress 2021

Dr Ariel Weinberger, CEO, Autonomous

Dr Ariel Weinberger | CEO | Autonomous » speaking at Antiviral Congress 2021

Daniela Weiskopf, Instructor, Division Of Vaccine Discovery, La Jolla Institute for Allergy and Immunology

Daniela Weiskopf | Instructor, Division Of Vaccine Discovery | La Jolla Institute for Allergy and Immunology » speaking at Antiviral Congress 2021

Dr Michael Wohlfeiler, Chief of Medicine, AIDS Healthcare Foundation

Dr Michael Wohlfeiler | Chief of Medicine | AIDS Healthcare Foundation » speaking at Antiviral Congress 2021

Mahesh Yadav, Principal Scientist, Oncology Biomarker Development, Genentech

Mahesh Yadav | Principal Scientist, Oncology Biomarker Development | Genentech » speaking at Antiviral Congress 2021

Dr Kevin Yeo, Director, Medical Affairs,, Emergent Biosolutions

Dr Kevin Yeo | Director, Medical Affairs, | Emergent Biosolutions » speaking at Antiviral Congress 2021

Arthur Young, President And Founder, InvVax Inc

Arthur Young | President And Founder | InvVax Inc » speaking at Antiviral Congress 2021

Dr Benjamin Young, Head Of Global Medical Directors, ViiV healthcare

Dr Benjamin Young | Head Of Global Medical Directors | ViiV healthcare » speaking at Antiviral Congress 2021

For conference programme and speaking opportunities:
Lauren Sheppard

lauren.sheppard@terrapinn.com

For sponsorship and exhibition opportunities:
Thomas Hall

thomas.hall@terrapinn.com